Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' events

Dr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which could result in patients receiving a double dose. The error poses serious health risks, including hypersensitivity, liver injury, and respiratory depression. The mislabeled batch was distributed nationwide between November 4 and 6, 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Bqjlzwr
via IFTTT